Lightnews — Scholar-powered news

Peter Singer @petersinger.bsky.social · 16d

On now — join us online sciencesummitnyc.org/science-summ...

2

Peter Singer @petersinger.bsky.social · 18d

Happy to speak at this session on data, innovation, and the future of global health #UNGA80

4

Reposted by Peter Singer

Natasha Loder @natashaloder.bsky.social · 22d

So @petersinger.bsky.social and I just published a piece about the "$6 revolution" in generic GLP-1 drugs in Canada's @theglobeandmail.com.

You can also read the original, longer version, on our Substacks. (see below)

www.theglobeandmail.com/opinion/arti...

Opinion: Canadians can benefit from tumbling prices on weight-loss drugs

Affordable semaglutide can improve the health outcomes for the more than 1 billion people living with obesity worldwide

www.theglobeandmail.com

1 4 7

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · 28d

Happy to write this piece with @natashaloder.bsky.social. Canada is in a unique position as the only G7 country which will soon have no patent protections for GLP-1 drugs. The opportunities are humungous. Read more about what we think should happen www.theglobeandmail.com/gift/2be7b2e...

Canadians can benefit from tumbling prices on weight-loss drugs

Affordable semaglutide can improve the health outcomes for the more than 1 billion people living with obesity worldwide

www.theglobeandmail.com

1 7 22

Peter Singer @petersinger.bsky.social · 28d

Happy to write this piece with @natashaloder.bsky.social. Canada is in a unique position as the only G7 country which will soon have no patent protections for GLP-1 drugs. The opportunities are humungous. Read more about what we think should happen www.theglobeandmail.com/gift/2be7b2e...

Canadians can benefit from tumbling prices on weight-loss drugs

Affordable semaglutide can improve the health outcomes for the more than 1 billion people living with obesity worldwide

www.theglobeandmail.com

1 7 22

Reposted by Peter Singer

André Picard @picardonhealth @picardonhealth.bsky.social · 28d

Canadians can benefit from tumbling prices on weight-loss drugs. Canada is in a unique position as the only G7 country where patent protection on semaglutide is about to lapse, by @petersinger.bsky.social @natashaloder.bsky.social www.theglobeandmail.com/opinion/arti... via @theglobeandmail.com

Opinion: Canadians can benefit from tumbling prices on weight-loss drugs

Affordable semaglutide can improve the health outcomes for the more than 1 billion people living with obesity worldwide

www.theglobeandmail.com

2 9 19

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · Sep 6

The WHO listing is a step in the right direction. But it’s only advice to governments. Its indications are also pretty conservative: diabetes w/ heart or kidney disease or w/ obesity. WHO could speed up availability by pre-qualifying GLP-1 manufacturers and updating its clinical guidelines.

2/n

1 1 9

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · Sep 7

Sept 5th: @who.int lists GLP-1 on Essential Medicines List. NVO and LLY shares drop. 🤷🏻‍♂️

1 5

Peter Singer @petersinger.bsky.social · Sep 7

Sept 5th: @who.int lists GLP-1 on Essential Medicines List. NVO and LLY shares drop. 🤷🏻‍♂️

1 5

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · Sep 6

Funding is also needed. @natashaloder.bsky.social & I outline several options for innovative finance for GLP-1 drugs and sketch the huge opportunity as the patent on semaglutide expires in many jurisdictions early next year. Check out our joint piece here: open.substack.com/pub/singerp/...

3/n

The $6 revolution. How generic weight loss drugs could save millions of lives.

The arrival of generic semaglutide is an unheard of opportunity for global public health

open.substack.com

1 1 13

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · Sep 6

On Sept 5th, @who.int listed GLP-1 drugs on its Essential Medicines List. This listing covers about 75% of the 2.1 m lives saved per year in the lower estimate of the model David Brook and I developed. See the details on the screenshot below from our preprint: www.medrxiv.org/content/10.1...

1/n

1 7 28

Reposted by Peter Singer

Ellen 't Hoen @ellenthoen.bsky.social · Sep 6

GLP-1 drugs have been on the Medicines Patent Pool priority list for a while. Time for the companies to come forward now @who.int labeled them essential @thirugeneva.bsky.social @medicinespatentpool.org

Peter Singer @petersinger.bsky.social · Sep 6

On Sept 5th, @who.int listed GLP-1 drugs on its Essential Medicines List. This listing covers about 75% of the 2.1 m lives saved per year in the lower estimate of the model David Brook and I developed. See the details on the screenshot below from our preprint: www.medrxiv.org/content/10.1...

1/n

1 3

Reposted by Peter Singer

Megan Ranney MD MPH @meganranney.bsky.social · Sep 6

Now this is an interesting idea.

Peter Singer @petersinger.bsky.social · Sep 6

Funding is also needed. @natashaloder.bsky.social & I outline several options for innovative finance for GLP-1 drugs and sketch the huge opportunity as the patent on semaglutide expires in many jurisdictions early next year. Check out our joint piece here: open.substack.com/pub/singerp/...

3/n

The $6 revolution. How generic weight loss drugs could save millions of lives.

The arrival of generic semaglutide is an unheard of opportunity for global public health

open.substack.com

11 27

Peter Singer @petersinger.bsky.social · Sep 6

@natashaloder.bsky.social and I will have more to say about this and other global health stuff in the weeks ahead. Follow us on our substacks.

Natasha’s substack: open.substack.com/pub/overmatt...

Peter’s substack: open.substack.com/pub/singerp?...

4/4 fin

Overmatter | Natasha Loder | Substack

Stories that matter. Click to read Overmatter, by Natasha Loder, a Substack publication with hundreds of subscribers.

open.substack.com

1 7

Peter Singer @petersinger.bsky.social · Sep 6

Funding is also needed. @natashaloder.bsky.social & I outline several options for innovative finance for GLP-1 drugs and sketch the huge opportunity as the patent on semaglutide expires in many jurisdictions early next year. Check out our joint piece here: open.substack.com/pub/singerp/...

3/n

The $6 revolution. How generic weight loss drugs could save millions of lives.

The arrival of generic semaglutide is an unheard of opportunity for global public health

open.substack.com

1 1 13

Peter Singer @petersinger.bsky.social · Sep 6

The WHO listing is a step in the right direction. But it’s only advice to governments. Its indications are also pretty conservative: diabetes w/ heart or kidney disease or w/ obesity. WHO could speed up availability by pre-qualifying GLP-1 manufacturers and updating its clinical guidelines.

2/n

1 1 9

Peter Singer @petersinger.bsky.social · Sep 6

On Sept 5th, @who.int listed GLP-1 drugs on its Essential Medicines List. This listing covers about 75% of the 2.1 m lives saved per year in the lower estimate of the model David Brook and I developed. See the details on the screenshot below from our preprint: www.medrxiv.org/content/10.1...

1/n

1 7 28

Peter Singer @petersinger.bsky.social · Sep 4

I was happy to participate in this @yalesph.bsky.social video about science and society

Yale School of Public Health @yalesph.bsky.social · Sep 4

Our vision is linking science and society, making public health foundational to communities everywhere.

We asked faculty, students, staff, and alumni to define this vision in their own words, as well as how they translate it into practice. Here's what they had to say.

Linking Science & Society

YouTube video by Yale School of Public Health

www.youtube.com

2 8

Reposted by Peter Singer

Natasha Loder @natashaloder.bsky.social · Sep 4

Tomorrow the WHO updates its essential medicines list—which over 150 countries adopt as policy. Will GLP-1 drugs be on the list?

Read my article with @petersinger.bsky.social which explains why such a shift could be an important next step

overmatter.substack.com/p/the-6-revo...

The $6 revolution. How generic weight loss drugs could save millions of lives.

The arrival of generic semaglutide is an unheard of opportunity for global public health

overmatter.substack.com

2 8

Reposted by Peter Singer

Peter Singer @petersinger.bsky.social · Aug 30

1 1

Reposted by Peter Singer

Steven Buchsbaum @stevebuchsbaum.bsky.social · Aug 30

Good reads at singerp.substack.com

3 2

Peter Singer @petersinger.bsky.social · Aug 30

1 1

Reposted by Peter Singer

Tamar Haspel @tamarhaspel.bsky.social · Aug 23

Details from @natashaloder.bsky.social and @petersinger.bsky.social

overmatter.substack.com/p/the-6-revo...

The $6 revolution. How generic weight loss drugs could save millions of lives.

The arrival of generic semaglutide is an unheard of opportunity for global public health

overmatter.substack.com

1 8

Reposted by Peter Singer

Natasha Loder @natashaloder.bsky.social · Aug 20

5/ The World Health Organization needs to step up. GLP-1 drugs deserve inclusion in global obesity strategies. Delay could mean hundreds of thousands of preventable deaths.

1 1 8

Reposted by Peter Singer

Natasha Loder @natashaloder.bsky.social · Aug 22

1️⃣ Earlier this month, the US health department—headed by RFK Jr.—terminated $500m contracts supposedly related to mRNA vaccines for respiratory viruses. Debunked safety concerns were cited as the reason.

But far more than this was cut. #Science #Vaccines #HealthPolicy #RNA #mRNA

1 3 7